Kumar D, Gemayel N S, Deapen D, Kapadia D, Yamashita P H, Lee M, Dwyer J H, Roy-Burman P, Bray G A, Mack T M
Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.
Diabetes. 1993 Sep;42(9):1351-63. doi: 10.2337/diab.42.9.1351.
In 224 twin pairs (132 monozygotic, 86 dizygotic, and 6 of uncertain zygosity) in whom the index twin had developed IDDM before 30 yr of age, 51 of the co-twins (38 monozygotic, 10 dizygotic, and 3 of uncertain zygosity) subsequently became diabetic. On the basis of concordance ratios, which were significantly discrepant (P < 0.01) between monozygotic and dizygotic twins, the substantial genetic role in IDDM etiology is confirmed. For the monozygotic co-twin of an IDDM case, the relative risk is significantly related to an early age at proband diagnosis (P < 0.01 for 0-4 vs. 5-9 yr of age). However, among monozygotic co-twins at any age, IDDM risk decreases as time passes after the proband diagnosis (P < 0.01 for 0-23 vs. > or = 24 mo after a proband diagnosis at 5-9 yr of age). Moreover, a structural-equation analysis suggests a profound contribution to liability (as much as 79%) from the twins' shared environment. Risk to like-sex male dizygotic co-twins is as high as that to monozygotic co-twins, significantly higher than that to like-sex female dizygotic co-twins (P < 0.005), and even higher than that to male co-twins in unlike-sex dizygotic pairs (P < 0.05). Overall, the risk to the dizygotic co-twin of a case is significantly higher (P < 0.001) than that to a non-twin sibling, as reported in the literature. The observed male excess is consistent with reported patterns of IDDM in experimental animals, and in certain circumstances in humans. Taken together, these observations suggest an important early acquired determinant of IDDM, independent of genetic determinants. On the basis of Kaplan-Meier IDDM-free survival curves, if the proband is diagnosed before 15 yr of age, the long-term risk to the co-twin is estimated at 44% (monozygotic) and 19% (dizygotic); it reaches 65% for the co-twin of a monozygotic proband diagnosed before 5 yr of age. An IDDM discordant period of no more than 3 yr was observed in 60% of the pairs destined to become concordant, offering a very brief window for intervention following the recognition of high risk.
在224对双胞胎(132对同卵双胞胎、86对异卵双胞胎以及6对合子性不确定的双胞胎)中,索引双胞胎在30岁之前患胰岛素依赖型糖尿病(IDDM),其中51名双胞胎(38名同卵双胞胎、10名异卵双胞胎以及3名合子性不确定的双胞胎)随后也患上了糖尿病。基于同卵双胞胎和异卵双胞胎之间显著不同(P < 0.01)的一致性比率,证实了遗传因素在IDDM病因中起着重要作用。对于IDDM患者的同卵双胞胎,相对风险与先证者诊断时的年龄显著相关(0 - 4岁与5 - 9岁相比,P < 0.01)。然而,在任何年龄的同卵双胞胎中,IDDM风险随着先证者诊断后的时间推移而降低(5 - 9岁的先证者诊断后0 - 23个月与≥24个月相比,P < 0.01)。此外,结构方程分析表明双胞胎的共享环境对患病易感性有很大贡献(高达79%)。同性男性异卵双胞胎的患病风险与同卵双胞胎一样高,显著高于同性女性异卵双胞胎(P < 0.005),甚至高于异性异卵双胞胎中的男性双胞胎(P < 0.05)。总体而言,如文献报道,病例的异卵双胞胎的患病风险显著高于非双胞胎兄弟姐妹(P < 0.001)。观察到的男性患病率较高与实验动物以及人类某些情况下报道的IDDM模式一致。综上所述,这些观察结果表明存在一个独立于遗传因素的重要的IDDM早期获得性决定因素。根据Kaplan - Meier无IDDM生存曲线,如果先证者在15岁之前被诊断,双胞胎的长期患病风险估计为44%(同卵双胞胎)和19%(异卵双胞胎);对于5岁之前被诊断的同卵双胞胎的双胞胎,该风险达到65%。在60%注定会患病一致的双胞胎对中,观察到IDDM不一致期不超过3年,这为识别高风险后进行干预提供了一个非常短暂的窗口。